Secondary gliosarcoma

A review of clinical features and pathological diagnosis. Clinical article

Seunggu (Jude) Han, Isaac Yang, Tarik Tihan, Susan M. Chang, Andrew T. Parsa

Research output: Contribution to journalReview article

26 Citations (Scopus)

Abstract

Object. Although secondary gliosarcoma after treatment of primary glioblastoma multiforme has been described, little is known of these rare tumors. In this article the authors review the literature on secondary gliosarcoma, with attention to clinical course and pathological features. Methods. A PubMed search of the key word intracranial "gliosarcoma" with and without "radiation" or "radiotherapy" in humans was performed. The 204 citations yielded were screened for relevancy to gliosarcomas that occur after treatment of previous intracranial neoplasms. Results. A search of the literature yielded 24 relevant articles, combined for a total of only 12 cases of secondary gliosarcoma and 12 cases of radiation-induced gliosarcoma. Of the 12 cases of secondary gliosarcoma, all were previously treated with surgery and radiotherapy (mean dose 50.7 Gy), with a mean survival of 13 months since time of gliosarcoma diagnosis (range 6.9-19.4 months). In the cases of radiation-induced gliosarcoma, the mean dose of previous radiotherapy was 51.3 Gy (median 54 Gy, range 24-60 Gy), and the mean survival since gliosarcoma diagnosis was 6.7 months (median 6 months, range 2-10 months). Conclusions. Secondary gliosarcoma and radiation-induced gliosarcoma are exceedingly rare. The literature on secondary gliosarcoma illustrates a more favorable survival than for primary gliosarcoma but remains limited regarding clinical and radiographic presentation, response to treatment, and pathogenesis. The results of the present review also support the notion that secondary gliosarcomas and radiation-induced gliosarcomas are distinct entities, with longer survival and shorter latency of gliosarcoma induction seen in the former. Efforts to elucidate the role of radiotherapy in the induction of gliosarcomas may yield new insights into therapeutic risks of cranial radiation and CNS tumor pathogenesis.

Original languageEnglish (US)
Pages (from-to)26-32
Number of pages7
JournalJournal of neurosurgery
Volume112
Issue number1
DOIs
StatePublished - Jan 1 2010
Externally publishedYes

Fingerprint

Gliosarcoma
Radiation
Radiotherapy
Survival

Keywords

  • Gliosarcoma
  • Radiation-induced gliosarcoma
  • Secondary gliosarcoma

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Secondary gliosarcoma : A review of clinical features and pathological diagnosis. Clinical article. / Han, Seunggu (Jude); Yang, Isaac; Tihan, Tarik; Chang, Susan M.; Parsa, Andrew T.

In: Journal of neurosurgery, Vol. 112, No. 1, 01.01.2010, p. 26-32.

Research output: Contribution to journalReview article

Han, Seunggu (Jude) ; Yang, Isaac ; Tihan, Tarik ; Chang, Susan M. ; Parsa, Andrew T. / Secondary gliosarcoma : A review of clinical features and pathological diagnosis. Clinical article. In: Journal of neurosurgery. 2010 ; Vol. 112, No. 1. pp. 26-32.
@article{9d4f3d2c5f7d4a908f17e4d79d4407f0,
title = "Secondary gliosarcoma: A review of clinical features and pathological diagnosis. Clinical article",
abstract = "Object. Although secondary gliosarcoma after treatment of primary glioblastoma multiforme has been described, little is known of these rare tumors. In this article the authors review the literature on secondary gliosarcoma, with attention to clinical course and pathological features. Methods. A PubMed search of the key word intracranial {"}gliosarcoma{"} with and without {"}radiation{"} or {"}radiotherapy{"} in humans was performed. The 204 citations yielded were screened for relevancy to gliosarcomas that occur after treatment of previous intracranial neoplasms. Results. A search of the literature yielded 24 relevant articles, combined for a total of only 12 cases of secondary gliosarcoma and 12 cases of radiation-induced gliosarcoma. Of the 12 cases of secondary gliosarcoma, all were previously treated with surgery and radiotherapy (mean dose 50.7 Gy), with a mean survival of 13 months since time of gliosarcoma diagnosis (range 6.9-19.4 months). In the cases of radiation-induced gliosarcoma, the mean dose of previous radiotherapy was 51.3 Gy (median 54 Gy, range 24-60 Gy), and the mean survival since gliosarcoma diagnosis was 6.7 months (median 6 months, range 2-10 months). Conclusions. Secondary gliosarcoma and radiation-induced gliosarcoma are exceedingly rare. The literature on secondary gliosarcoma illustrates a more favorable survival than for primary gliosarcoma but remains limited regarding clinical and radiographic presentation, response to treatment, and pathogenesis. The results of the present review also support the notion that secondary gliosarcomas and radiation-induced gliosarcomas are distinct entities, with longer survival and shorter latency of gliosarcoma induction seen in the former. Efforts to elucidate the role of radiotherapy in the induction of gliosarcomas may yield new insights into therapeutic risks of cranial radiation and CNS tumor pathogenesis.",
keywords = "Gliosarcoma, Radiation-induced gliosarcoma, Secondary gliosarcoma",
author = "Han, {Seunggu (Jude)} and Isaac Yang and Tarik Tihan and Chang, {Susan M.} and Parsa, {Andrew T.}",
year = "2010",
month = "1",
day = "1",
doi = "10.3171/2009.3.JNS081081",
language = "English (US)",
volume = "112",
pages = "26--32",
journal = "Journal of Neurosurgery",
issn = "0022-3085",
publisher = "American Association of Neurological Surgeons",
number = "1",

}

TY - JOUR

T1 - Secondary gliosarcoma

T2 - A review of clinical features and pathological diagnosis. Clinical article

AU - Han, Seunggu (Jude)

AU - Yang, Isaac

AU - Tihan, Tarik

AU - Chang, Susan M.

AU - Parsa, Andrew T.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Object. Although secondary gliosarcoma after treatment of primary glioblastoma multiforme has been described, little is known of these rare tumors. In this article the authors review the literature on secondary gliosarcoma, with attention to clinical course and pathological features. Methods. A PubMed search of the key word intracranial "gliosarcoma" with and without "radiation" or "radiotherapy" in humans was performed. The 204 citations yielded were screened for relevancy to gliosarcomas that occur after treatment of previous intracranial neoplasms. Results. A search of the literature yielded 24 relevant articles, combined for a total of only 12 cases of secondary gliosarcoma and 12 cases of radiation-induced gliosarcoma. Of the 12 cases of secondary gliosarcoma, all were previously treated with surgery and radiotherapy (mean dose 50.7 Gy), with a mean survival of 13 months since time of gliosarcoma diagnosis (range 6.9-19.4 months). In the cases of radiation-induced gliosarcoma, the mean dose of previous radiotherapy was 51.3 Gy (median 54 Gy, range 24-60 Gy), and the mean survival since gliosarcoma diagnosis was 6.7 months (median 6 months, range 2-10 months). Conclusions. Secondary gliosarcoma and radiation-induced gliosarcoma are exceedingly rare. The literature on secondary gliosarcoma illustrates a more favorable survival than for primary gliosarcoma but remains limited regarding clinical and radiographic presentation, response to treatment, and pathogenesis. The results of the present review also support the notion that secondary gliosarcomas and radiation-induced gliosarcomas are distinct entities, with longer survival and shorter latency of gliosarcoma induction seen in the former. Efforts to elucidate the role of radiotherapy in the induction of gliosarcomas may yield new insights into therapeutic risks of cranial radiation and CNS tumor pathogenesis.

AB - Object. Although secondary gliosarcoma after treatment of primary glioblastoma multiforme has been described, little is known of these rare tumors. In this article the authors review the literature on secondary gliosarcoma, with attention to clinical course and pathological features. Methods. A PubMed search of the key word intracranial "gliosarcoma" with and without "radiation" or "radiotherapy" in humans was performed. The 204 citations yielded were screened for relevancy to gliosarcomas that occur after treatment of previous intracranial neoplasms. Results. A search of the literature yielded 24 relevant articles, combined for a total of only 12 cases of secondary gliosarcoma and 12 cases of radiation-induced gliosarcoma. Of the 12 cases of secondary gliosarcoma, all were previously treated with surgery and radiotherapy (mean dose 50.7 Gy), with a mean survival of 13 months since time of gliosarcoma diagnosis (range 6.9-19.4 months). In the cases of radiation-induced gliosarcoma, the mean dose of previous radiotherapy was 51.3 Gy (median 54 Gy, range 24-60 Gy), and the mean survival since gliosarcoma diagnosis was 6.7 months (median 6 months, range 2-10 months). Conclusions. Secondary gliosarcoma and radiation-induced gliosarcoma are exceedingly rare. The literature on secondary gliosarcoma illustrates a more favorable survival than for primary gliosarcoma but remains limited regarding clinical and radiographic presentation, response to treatment, and pathogenesis. The results of the present review also support the notion that secondary gliosarcomas and radiation-induced gliosarcomas are distinct entities, with longer survival and shorter latency of gliosarcoma induction seen in the former. Efforts to elucidate the role of radiotherapy in the induction of gliosarcomas may yield new insights into therapeutic risks of cranial radiation and CNS tumor pathogenesis.

KW - Gliosarcoma

KW - Radiation-induced gliosarcoma

KW - Secondary gliosarcoma

UR - http://www.scopus.com/inward/record.url?scp=75749125830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75749125830&partnerID=8YFLogxK

U2 - 10.3171/2009.3.JNS081081

DO - 10.3171/2009.3.JNS081081

M3 - Review article

VL - 112

SP - 26

EP - 32

JO - Journal of Neurosurgery

JF - Journal of Neurosurgery

SN - 0022-3085

IS - 1

ER -